Autoimmune Overlap: When Pattern Loss Coexists With Areata or Thyroid

AGA and alopecia areata are not mutually exclusive — they can coexist in the same patient. Distinguishing them and identifying overlap has direct treatment implications that are often missed in telehealth evaluations.

Alopecia areata and androgenetic alopecia are driven by entirely different biological mechanisms, but they share patients — both conditions are common enough that coincidence is frequent, and each can mask or complicate the clinical presentation of the other.

Distinguishing AGA from areata clinically

The classic distinctions: AGA progresses gradually over years in androgen-sensitive zones (vertex, frontal, temporal) with miniaturisation visible on trichoscopy. Alopecia areata presents as circumscribed patches of complete hair absence, often with exclamation mark hairs (short broken hairs at patch margins), preserved or regrown vellus hair within patches, and a positive pull test at patch borders during active disease.

Trichoscopy differentiates the two: AGA shows follicular unit heterogeneity (mixed terminal and vellus hairs, peripilar signs) in a patterned zone; areata shows yellow dots (empty follicles with sebum), black dots (broken proximal hairs), and exclamation mark hairs in the patch with normal follicle morphology in surrounding scalp.

Coexistence scenarios

AGA with superimposed areata: An AGA patient experiences sudden additional patchy loss — an areata episode on top of ongoing pattern loss. The patchy component may be attributed to AGA progression rather than autoimmune attack, delaying appropriate areata-specific treatment (corticosteroids, JAK inhibitors).

Areata resolving to reveal AGA: A patient recovering from areata through immunosuppression finds that the regrown hair is finer and less dense in vertex and frontal zones than the pre-areata baseline — the revealed AGA was masked during the acute autoimmune episode by the more acute presentation.

Autoimmune thyroid disease

Hashimoto's thyroiditis (autoimmune hypothyroidism) is the most common autoimmune condition in men after AGA, and the two frequently coexist. Hashimoto's-driven hypothyroidism produces diffuse telogen effluvium — different pattern from AGA but additive to it. TSH testing is warranted in men with AGA showing accelerated or unexpectedly diffuse shedding beyond what the androgen-driven component explains. Normalising thyroid function with appropriate hormone replacement reduces the TE component without addressing the AGA component.

Lupus and other systemic autoimmune diseases

Systemic lupus erythematosus (SLE) causes both non-scarring diffuse hair loss (TE) and, less commonly, discoid lupus lesions of the scalp that produce scarring alopecia. Scalp lupus may occur in men without the classic SLE diagnosis. Lesions are typically discoid, erythematous, and scarring — clearly distinct from AGA on examination — but require biopsy for definitive diagnosis when in doubt.